Skip to main content
Log in

Comparison of in situ hybridization and immunocytochemistry for the detection of residual beta cells in the pancreas of streptozotocin-treated diabetic rats

  • Originals
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

The relative efficacy of immunocytochemistry versus in situ hybridization in identifying residual beta cells was studied in rats with streptozotocin-induced diabetes. Consecutive sections of pancreas of streptozotocin-treated diabetic rats and control animals were alternately subjected to in situ hybridization (synthetic oligonucleotides complementary to rat preproinsulin mRNA) and immunocytochemistry (monoclonal antibodies to insulin). The results obtained with both methods were quantitated with the use of computer-assisted image analysis, and the ratio of cells positive by immunocytochemistry to those positive by in situ hybridization was determined. Under normoglycaemic conditions the values obtained by immunocytochemistry correlated well with those obtained by in situ hybridization (immuno/in situ > 95%). In the streptozotocin diabetic animals, however, immunocytochemistry resulted in a distinct underestimation of the number of residual beta cells (immuno/in situ < 80%). This difference was even more striking in small islet cell clusters (<100 μm) immuno/in situ 20%). These results suggest that in situ hybridization for prohormone mRNA is the method of choice for the identification of residual or regenerating beta cells with very low insulin content. Caution should be used when interpreting quantitative data in diabetic conditions that are based exclusively on immunocytochemical detection methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jennette JG, Immunohistology in diagnostic pathology. CRC Press, Boca Raton, Fla., 1989

    Google Scholar 

  2. Oberholzer M, Ettlin RA, Klöppel G, Löhr M, Buser MW, Mihatsch WJ, Christen H, Marti U, Heitz PU, Morphometry and immunocytochemistry. Anal Quant Cytol Histol 9: 123–132, 1987

    Google Scholar 

  3. Channaoui K, Rahier J, Influence of the decrease of intracellular antigenic content on morphometric analysis: effect of the type and dilution of the first antibody. Histochemistry 97: 389–395, 1992

    Google Scholar 

  4. Logothetopoulos J, Davidson K, Haist E, Best H, Degranulation of beta cells and loss of pancreatic insulin after infusions of insulin antibody or glucose. Diabetes 14: 493–500, 1965

    Google Scholar 

  5. Klöppel G, Altenähr E, Freytag G, Electronmicroscopical findings on insulitis in mice injected with insulin antibody. Acta Endocrinol (Copenh) 155: 194–199, 1971

    Google Scholar 

  6. Rakienten N, Rakienten MC, Nadkarni MW, Studies on the diabetogenic action of streptozotocin. Cancer Chemother Res 29: 91–98, 1963

    Google Scholar 

  7. Brosky G, Logothetopoulos J, Streptozotocin diabetes in the mouse and guinea pig. Diabetes 18: 606–611, 1969

    Google Scholar 

  8. Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, Unger RH, Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci USA 73: 1338–1342, 1976

    Google Scholar 

  9. Cordell B, Bell G, Tischer E, DeNoto F, Ullrich A, Pictet R, Rutter J, Goodman H, Isolation and characterization of a cloned rat insulin gene. Cell 18: 533–543, 1979

    Google Scholar 

  10. Lomedico P, Rosenthal N, Efstratiadis N, Gilbert W, Kolodner R, Tizard R, The structure and evolution of the two nonallelic rat preproinsulin genes. Cell 18: 545–558, 1979

    Google Scholar 

  11. Pipeleers D, In't Veld P, Winkel M Van de, Maes E, Schuit F, Gepts W, A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117: 806–816, 1985

    Google Scholar 

  12. Lloyd RV, Use of molecular probes in the study of endocrine disease. Hum Pathol 18: 1199–1211, 1987

    Google Scholar 

  13. Chen L, Komiya I, Inman L, McCorkle K, Alam T, Unger RH, Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry. Proc Natl Acad Sci USA 86: 1367–1371, 1989

    Google Scholar 

  14. Chen L, Komiya I, Inman L, Appel M, Alam T, Unger R, Effects of hypoglycaemia and prolonged fasting on insulin and glucagon gene expression. J Clin Invest 84: 711–714, 1989

    Google Scholar 

  15. Shorrock K, Roberts P, Pringle JH, Lauder I, Demonstration of insulin and glucagon mRNA in routinely fixed and processed pancreatic tissue by in situ hybridization. J Pathol 165: 105–110, 1991

    Google Scholar 

  16. Hamid Q, Corrin B, Sheppard N, Huttner WB, Polak JM, Expression of chromogranin A mRNA in small cell carcinoma of the lung. J Pathol 163: 293–297, 1991

    Google Scholar 

  17. Uhlig H, Saeger W, Fehr S, Lüdecke D, Detection of growth hormone, prolactin and human β-chorionic gonadotropin mRNA in growth hormone secreting pituitary adenomas by in situ hybridization. Virchows Arch [A] 418: 539–546, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Gompel, J., Mahler, T., De Paepe, M. et al. Comparison of in situ hybridization and immunocytochemistry for the detection of residual beta cells in the pancreas of streptozotocin-treated diabetic rats. Acta Diabetol 30, 118–122 (1993). https://doi.org/10.1007/BF00572853

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00572853

Key words

Navigation